A Phase 1 Study to Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

Clinical trial NCT05178901 · COMPLETED

Trial details

NCT number: NCT05178901
Sponsor: Public Health Vaccines LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Nipah Virus Infection

Start date: 2022-01-10
Primary completion: 2023-05-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.